Eculizumab as rescue therapy for severe antibody-mediated rejection after heart transplantation in complex congenital heart disease

11 May 2026 (14:30 - 14:39)
Organised by: Logo
Congress Presentation Part of: Challenging cases in heart transplantation Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by